# Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)

> **NCT00002027** · NA · COMPLETED · sponsor: **Janssen, LP** · enrollment: 60 (—)

## Conditions studied

- Cryptosporidiosis
- HIV Infections

## Interventions

- **DRUG:** Diclazuril

## Key facts

- **NCT ID:** NCT00002027
- **Lead sponsor:** Janssen, LP
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002027, "Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00002027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
